Rw. Tyl et al., ASSESSMENT OF THE DEVELOPMENTAL TOXICITY OF ETHYLENE-GLYCOL APPLIED CUTANEOUSLY TO CD-1 MICE, Fundamental and applied toxicology, 27(2), 1995, pp. 155-166
Ethylene glycol (EG; CAS No. 107-21-1) is teratogenic to mice by whole
-body exposure to an aerosol at high concentrations, but results were
confounded by possible exposure from ingestion after grooming and/or f
rom percutaneous absorption. Therefore, CD-1 mice were exposed to EG o
n Gestational Days (GD) 6 through 15, 6 hr/day by occluded cutaneous a
pplication at 0, 12.5, 50, or 100% (undiluted) EG (0.1 ml/animal, equi
valent to similar to 0, 404, 1677, or 3549 mg/kg/day, respectively) or
by gavage on GD 6 through 15 at 3000 mg/kg/day [10 ml/kg, positive co
ntrol gavage group (PCGG)], 30 females/group. Dams were weighed and ev
aluated daily (including application site) for clinical signs and wate
r consumption throughout gestation. On GD 18, maternal uterus, liver,
and paired kidneys were weighed; kidneys of 0 and 100% and the PCGG we
re examined microscopically. Corpora lutea and implantation sites were
recorded. Live fetuses were weighed, sexed, and examined for structur
al alterations. For cutaneously exposed dams, there was no treatment-r
elated maternal toxicity, no differences in pre- or postimplantation l
oss or in fetal body weights/ litter, and no increased incidences of a
ny fetal malformations. Two skeletal variations, increased at 100%, ma
y represent effects of restraint stress and/or findings due to chance.
In the PCGG, 8 females (26.7%) died, water consumption was increased,
fetal body weights/litter were reduced, and fetal malformations and v
ariations were increased. PCGG kidneys exhibited tubular nephrosis and
tubular cell degeneration, with no oxalate crystals, documenting rena
l toxicity at this oral dose in mice. Minimal-grade renal tubular lesi
ons observed in 3 mice (of 30) at 100% EG may represent treatment-rela
ted or incidental findings. Therefore, exposure of pregnant CD-1 mice
to 0, 12.5, 50, or 100% EG during organogenesis by occluded cutaneous
application resulted in minimal or no observable maternal or developme
ntal toxicity at 100% (similar to 3549 mg/kg/day), the NOEL. (C) 1995
Society of Toxicology